Nantahala Capital Management, LLC Abeona Therapeutics Inc. Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
A detailed history of Nantahala Capital Management, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 3,509,850 shares of ABEO stock, worth $21.5 Million. This represents 0.75% of its overall portfolio holdings.
Number of Shares
3,509,850
Previous 520,000
574.97%
Holding current value
$21.5 Million
Previous $2.89 Million
478.86%
% of portfolio
0.75%
Previous 0.15%
Shares
10 transactions
Others Institutions Holding ABEO
# of Institutions
77Shares Held
27.8MCall Options Held
556KPut Options Held
34.9K-
Suvretta Capital Management, LLC New York, NY3.69MShares$22.6 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.69MShares$16.5 Million0.02% of portfolio
-
Western Standard LLC Los Angeles, CA2.28MShares$14 Million6.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$12.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.84MShares$11.3 Million2.38% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $36.4M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...